Impact of Anxiety and Depression in Patients with Atrial Fibrillation: Insights from Two International Prospective Registries

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Cardiovascular Risk and Diseases

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Cardiovasc Diabetol

Romiti GF, Mei DA, Corica B, Proietti M, Boriani G, Olshansky B, Chao TF, Huisman MV, Lip GYH, GLORIA-AF Investigators

doi: 10.1186/s12933-025-02950-y

Atrial Fibrillation

Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: Insights from 2 real-world prospective registries across Europe and East Asia

Heart Rhythm

Askarinejad A, Bucci T, Tartaglia E, Rossi M, Rigutini AG, Tse HF, Boriani G, Chao TF, Lip GYH

doi: 10.1016/j.hrthm.2026.02.038

Atrial Fibrillation

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

Clin Res Cardiol

Yildirim M, Salbach C, Dürr J, Mueller-Hennessen M, Katus HA, Frey N, Giannitsis E

doi: 10.1007/s00392-026-02912-8

Atrial Fibrillation

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

J Am Heart Assoc

Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, Huisman MV, Lip GYH, GLORIA‐AF Investigators

doi: 10.1161/JAHA.125.044293

Atrial Fibrillation

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Am Heart J

Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G, Lucci D, Marin F, Potpara TS, Sanaullah A, Tokmakova M, Johnsen SP, Maggioni AP, AFFIRMO Study Investigators and Consortium

doi: 10.1016/j.ahj.2026.107356

Atrial FibrillationFurther Publications

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

Circ Arrhythm Electrophysiol

Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A, Diouf Y, Jacon P, Fauchier L

doi: 10.1161/CIRCEP.125.014101

Atrial Fibrillation

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

J Am Heart Assoc

Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S

doi: 10.1161/JAHA.125.044113

Atrial Fibrillation

Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation - insights from the COMPARE-CRYO study using continuous rhythm monitoring

Heart Rhythm

Iqbal SUR, Kueffer T, Knecht S, Badertscher P, Maurhofer J, Krisai P, Jufer C, Thalmann G, Heg D, Servatius H, Tanner H, Kühne M, Roten L, Sticherling C, Reichlin T, COMPARE-CRYO Trial investigators

doi: 10.1016/j.hrthm.2025.09.026

Related content

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: Insights from 2 real-world prospective registries across Europe and East Asia

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation - insights from the COMPARE-CRYO study using continuous rhythm monitoring